Search - tctmd.com

Displaying 261 - 280 of 302

Sort: Relevancy | Date

Presentation TCT 2012

Contrast-Induced Nephrotoxicity

Presenter: Roxana Mehran

October 22, 2012

News Daily News

La Bivalirudina Reduce las Hemorragias en Pacientes NSTEMI sometidos a PCI

Jason Kahn

October 19, 2012

News Daily News

Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI

Jason Kahn

October 19, 2012

News Industry News

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012(2)

October 16, 2012

News Industry News

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012

October 16, 2012

News Daily News

Reversible Anticoagulation Shows Promise for ACS Patients Undergoing Catheterization

August 14, 2012

News Daily News

La Anticoagulación Reversible parece Prometedora en Pacientes con SCA sometidos a Cateterización

August 14, 2012

Presentation SCAI 2012

Left Main/Multivessel PCI v. CABG: Where Are They Today?

Presenter: Roxana Mehran

May 09, 2012

News Industry News

OrbusNeich’s Combo Dual Therapy Stent™ Featured During Symposium at Angioplasty Summit TCTAP 2012

April 25, 2012

Presentation Fellows 2012

Oral Antiplatelet Agents in PCI and ACS

Presenter: Roxana Mehran

April 22, 2012

News Daily News

El Tratamiento Agresivo con Estatinas Reduce la Carga Lipídica de las Lesiones Obstructivas

April 05, 2012

News Daily News

Aggressive Statin Therapy Lowers Lipid Burden in Obstructive Lesions

April 05, 2012

News Daily News

Los Criterios del BARC Validados frente a las Definiciones Hemorrágicas Existentes

Leah Lawrence

March 23, 2012

Presentation PCI Outcomes 2012

Case 3: A Patient with Recurrent Stent Thrombosis

Presenter: Roxana Mehran

March 23, 2012

News Daily News

BARC Criteria Validated Against Existing Bleeding Definitions

Leah Lawrence

March 23, 2012

Presentation CIT 2012

How to start and set up a Research Program? The Basic Tools

Presenter: Roxana Mehran

March 15, 2012

News Daily News

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

Yael L. Maxwell

February 15, 2012

News Daily News

Induced Diuresis with Matched Hydration Reduces Contrast Nephropathy

January 17, 2012

Presentation TCT 2012

Use of the REG1 Anticoagulation System During PCI May Improve Bleeding and Ischemic Complications Compared with Heparin: A PCI Substudy from the Phase 2B RADAR Trial

Presenter: Thomas J. Povsic, John P. Vavalle, Laura H. Aberle, Steven L. Zelenkofske, Roxana Mehran, Mauricio G. Cohen, Christopher E. Buller, Jan H. Cornel, Jaroslaw D. Kasprzak, Gilles Montalescot, Peter Fail, Ian J. Sarembock, John H. Alexander

January 03, 2012

Presentation TCT 2012

The Utility of Three Primary Prevention Scoring Systems (Framingham, PROCAM, and SCORE) in Predicting Future Events in Patients with Acute Coronary Syndromes: The PROSPECT Trial

Presenter: Jung-Won Suh, Gary S. Mintz, Giora Weisz, Akiko Maehara, Ke Xu, Alexandra J. Lansky, Ecaterina Cristea, Roxana Mehran, John McPherson, Naim Farhat, Steven P. Marso, Bernard de Bruyne, Patrick W. Serruys, Gregg W. Stone

January 03, 2012

Advertisement

Contrast-Induced Nephrotoxicity

La Bivalirudina Reduce las Hemorragias en Pacientes NSTEMI sometidos a PCI

Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012(2)

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012

Reversible Anticoagulation Shows Promise for ACS Patients Undergoing Catheterization

La Anticoagulación Reversible parece Prometedora en Pacientes con SCA sometidos a Cateterización

Left Main/Multivessel PCI v. CABG: Where Are They Today?

OrbusNeich’s Combo Dual Therapy Stent™ Featured During Symposium at Angioplasty Summit TCTAP 2012

Oral Antiplatelet Agents in PCI and ACS

El Tratamiento Agresivo con Estatinas Reduce la Carga Lipídica de las Lesiones Obstructivas

Aggressive Statin Therapy Lowers Lipid Burden in Obstructive Lesions

Los Criterios del BARC Validados frente a las Definiciones Hemorrágicas Existentes

Case 3: A Patient with Recurrent Stent Thrombosis

BARC Criteria Validated Against Existing Bleeding Definitions

How to start and set up a Research Program? The Basic Tools

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

Induced Diuresis with Matched Hydration Reduces Contrast Nephropathy

Use of the REG1 Anticoagulation System During PCI May Improve Bleeding and Ischemic Complications Compared with Heparin: A PCI Substudy from the Phase 2B RADAR Trial

The Utility of Three Primary Prevention Scoring Systems (Framingham, PROCAM, and SCORE) in Predicting Future Events in Patients with Acute Coronary Syndromes: The PROSPECT Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content